1. Home
  2. EYPT vs LASR Comparison

EYPT vs LASR Comparison

Compare EYPT & LASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • LASR
  • Stock Information
  • Founded
  • EYPT 1987
  • LASR 2000
  • Country
  • EYPT United States
  • LASR United States
  • Employees
  • EYPT N/A
  • LASR N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • LASR Semiconductors
  • Sector
  • EYPT Industrials
  • LASR Technology
  • Exchange
  • EYPT Nasdaq
  • LASR Nasdaq
  • Market Cap
  • EYPT 390.0M
  • LASR 412.8M
  • IPO Year
  • EYPT 2005
  • LASR 2018
  • Fundamental
  • Price
  • EYPT $5.38
  • LASR $12.76
  • Analyst Decision
  • EYPT Strong Buy
  • LASR Strong Buy
  • Analyst Count
  • EYPT 7
  • LASR 4
  • Target Price
  • EYPT $24.00
  • LASR $15.13
  • AVG Volume (30 Days)
  • EYPT 610.5K
  • LASR 354.4K
  • Earning Date
  • EYPT 05-07-2025
  • LASR 05-08-2025
  • Dividend Yield
  • EYPT N/A
  • LASR N/A
  • EPS Growth
  • EYPT N/A
  • LASR N/A
  • EPS
  • EYPT N/A
  • LASR N/A
  • Revenue
  • EYPT $56,042,000.00
  • LASR $205,689,000.00
  • Revenue This Year
  • EYPT N/A
  • LASR $8.26
  • Revenue Next Year
  • EYPT N/A
  • LASR $10.40
  • P/E Ratio
  • EYPT N/A
  • LASR N/A
  • Revenue Growth
  • EYPT 12.04
  • LASR 2.66
  • 52 Week Low
  • EYPT $3.91
  • LASR $6.20
  • 52 Week High
  • EYPT $21.26
  • LASR $14.73
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 43.45
  • LASR 77.07
  • Support Level
  • EYPT $5.75
  • LASR $7.88
  • Resistance Level
  • EYPT $6.29
  • LASR $13.38
  • Average True Range (ATR)
  • EYPT 0.47
  • LASR 0.49
  • MACD
  • EYPT -0.11
  • LASR 0.63
  • Stochastic Oscillator
  • EYPT 0.00
  • LASR 87.90

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About LASR nLIGHT Inc.

nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.

Share on Social Networks: